BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8726543)

  • 1. Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide in alcohol and drug withdrawal.
    Lichtigfeld FJ; Gillman MA
    Clin Neuropharmacol; 1996 Jun; 19(3):246-51. PubMed ID: 8726543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state.
    Gillman MA; Lichtigfeld FJ
    J Subst Abuse Treat; 2002 Apr; 22(3):129-34. PubMed ID: 12039615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic analgesic nitrous oxide for alcohol withdrawal.
    Gillman MA
    Am J Health Syst Pharm; 2008 Dec; 65(23):2205, 2210; author reply 2210. PubMed ID: 19020183
    [No Abstract]   [Full Text] [Related]  

  • 4. Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal.
    Gillman MA; Lichtigfeld FJ
    Addict Behav; 2004 Aug; 29(6):1183-7. PubMed ID: 15236821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumbal μ-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats.
    Uhari-Väänänen J; Raasmaja A; Bäckström P; Oinio V; Airavaara M; Piepponen P; Kiianmaa K
    Alcohol Clin Exp Res; 2016 Oct; 40(10):2114-2123. PubMed ID: 27508965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.
    Rose JH; Karkhanis AN; Chen R; Gioia D; Lopez MF; Becker HC; McCool BA; Jones SR
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26625893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical role and mechanisms of action of analgesic nitrous oxide.
    Gillman MA; Lichtigfeld FJ
    Int J Neurosci; 1998 Feb; 93(1-2):55-62. PubMed ID: 9604169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic analgesic nitrous oxide for alcoholic withdrawal states.
    Gillman MA; Lichtigfeld FJ; Young TN
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005190. PubMed ID: 17443576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine acutely and persistently attenuates nonvesicular GABA release in rat nucleus accumbens.
    Schoffelmeer AN; Wardeh G; Vanderschuren LJ
    Synapse; 2001 Nov; 42(2):87-94. PubMed ID: 11574945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco.
    Daynes G; Gillman MA
    Int J Neurosci; 1994 May; 76(1-2):13-6. PubMed ID: 7960461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid properties of psychotropic analgesic nitrous oxide (laughing gas).
    Gillman MA; Lichtigfeld FJ
    Perspect Biol Med; 1994; 38(1):125-38. PubMed ID: 7997355
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
    Xiong W; Yu LC
    Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state.
    Lichtigfeld FJ; Gillman MA
    Int J Neurosci; 1994 May; 76(1-2):17-33. PubMed ID: 7960465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic analgesic nitrous oxide (PAN) for hyperactivity.
    de Wet J; Lichtigfeld FJ; Gillman MA
    Aust N Z J Psychiatry; 2001 Aug; 35(4):543-4. PubMed ID: 11531742
    [No Abstract]   [Full Text] [Related]  

  • 16. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
    Cui CL; Wu LZ; Han JS
    Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
    Capasso A; Sorrentino L; Pinto A
    Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol.
    Fan LW; Tien LT; Tanaka S; Ma T; Chudapongse N; Sinchaisuk S; Rockhold RW; Ho IK
    Neuroscience; 2003; 121(4):1063-74. PubMed ID: 14580956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting.
    Ojutkangas R; Gillman MA
    Int J Neurosci; 1994 May; 76(1-2):35-9. PubMed ID: 7960466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic nitrous oxide for alcohol withdrawal is better than placebo.
    Lichtigfeld FJ; Gillman MA
    Int J Neurosci; 1989 Nov; 49(1-2):71-4. PubMed ID: 2691421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.